Mark L Rubinstein1, Kevin Delucchi2,3, Neal L Benowitz4, Danielle E Ramo2,3. 1. Division of Adolescent Medicine, mark.rubinstein@ucsf.edu. 2. Department of Psychiatry, and. 3. Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California. 4. Division of Clinical Pharmacology and Experimental Therapeutics, Departments of Medicine and Bioengineering and Therapeutic Sciences.
Abstract
BACKGROUND: There is an urgent need to understand the safety of e-cigarettes with adolescents. We sought to identify the presence of chemical toxicants associated with e-cigarette use among adolescents. METHODS: Adolescent e-cigarette users (≥1 use within the past 30 days, ≥10 lifetime e-cigarette use episodes) were divided into e-cigarette-only users (no cigarettes in the past 30 days, urine 4-[methylnitrosamino]-1-[3-pyridyl]-1-butanol [NNAL] level <1 pg/mL of creatinine; n = 67), dual users (use of cigarettes in the past 30 days in addition to e-cigarettes, NNAL level >30 pg/mL; n = 16), and never-using controls (N = 20). Saliva was collected within 24 hours of the last e-cigarette use for analysis of cotinine and urine for analysis of NNAL and levels of 8 volatile organic chemical compounds. Bivariate analyses compared e-cigarette-only users with dual users, and regression analyses compared e-cigarette-only users with dual users and controls on levels of toxicants. RESULTS: The participants were 16.4 years old on average. Urine excretion of metabolites of benzene, ethylene oxide, acrylonitrile, acrolein, and acrylamide was significantly higher in dual users versus e-cigarette-only users (all P < .05). Excretion of metabolites of acrylonitrile, acrolein, propylene oxide, acrylamide, and crotonaldehyde were significantly higher in e-cigarette-only users compared with controls (all P < .05). CONCLUSIONS: Although e-cigarette vapor may be less hazardous than tobacco smoke, our findings can be used to challenge the idea that e-cigarette vapor is safe, because many of the volatile organic compounds we identified are carcinogenic. Messaging to teenagers should include warnings about the potential risk from toxic exposure to carcinogenic compounds generated by these products.
BACKGROUND: There is an urgent need to understand the safety of e-cigarettes with adolescents. We sought to identify the presence of chemical toxicants associated with e-cigarette use among adolescents. METHODS: Adolescent e-cigarette users (≥1 use within the past 30 days, ≥10 lifetime e-cigarette use episodes) were divided into e-cigarette-only users (no cigarettes in the past 30 days, urine 4-[methylnitrosamino]-1-[3-pyridyl]-1-butanol [NNAL] level <1 pg/mL of creatinine; n = 67), dual users (use of cigarettes in the past 30 days in addition to e-cigarettes, NNAL level >30 pg/mL; n = 16), and never-using controls (N = 20). Saliva was collected within 24 hours of the last e-cigarette use for analysis of cotinine and urine for analysis of NNAL and levels of 8 volatile organic chemical compounds. Bivariate analyses compared e-cigarette-only users with dual users, and regression analyses compared e-cigarette-only users with dual users and controls on levels of toxicants. RESULTS: The participants were 16.4 years old on average. Urine excretion of metabolites of benzene, ethylene oxide, acrylonitrile, acrolein, and acrylamide was significantly higher in dual users versus e-cigarette-only users (all P < .05). Excretion of metabolites of acrylonitrile, acrolein, propylene oxide, acrylamide, and crotonaldehyde were significantly higher in e-cigarette-only users compared with controls (all P < .05). CONCLUSIONS: Although e-cigarette vapor may be less hazardous than tobacco smoke, our findings can be used to challenge the idea that e-cigarette vapor is safe, because many of the volatile organic compounds we identified are carcinogenic. Messaging to teenagers should include warnings about the potential risk from toxic exposure to carcinogenic compounds generated by these products.
Authors: Gideon St Helen; Peyton Jacob; Margaret Peng; Delia A Dempsey; S Katharine Hammond; Neal L Benowitz Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-11-14 Impact factor: 4.254
Authors: Stephen S Hecht; Steven G Carmella; Delshanee Kotandeniya; Makenzie E Pillsbury; Menglan Chen; Benjamin W S Ransom; Rachel Isaksson Vogel; Elizabeth Thompson; Sharon E Murphy; Dorothy K Hatsukami Journal: Nicotine Tob Res Date: 2014-10-21 Impact factor: 4.244
Authors: Kim Pulvers; Ashley S Emami; Nicole L Nollen; Devan R Romero; David R Strong; Neal L Benowitz; Jasjit S Ahluwalia Journal: Nicotine Tob Res Date: 2018-01-05 Impact factor: 4.244
Authors: Maciej L Goniewicz; Christopher M Havel; Margaret Wilson Peng; Peyton Jacob; Delia Dempsey; Lisa Yu; Wioleta Zielinska-Danch; Bartosz Koszowski; Jan Czogala; Andrzej Sobczak; Neal L Benowitz Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-12 Impact factor: 4.254
Authors: Peyton Jacob; Christopher Havel; Do-Hoon Lee; Lisa Yu; Mark D Eisner; Neal L Benowitz Journal: Anal Chem Date: 2008-10-08 Impact factor: 6.986
Authors: Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz Journal: Tob Control Date: 2013-03-06 Impact factor: 7.552
Authors: Cristina Miliano; E Reilly Scott; Laura B Murdaugh; Emma R Gnatowski; Christine L Faunce; Megan S Anderson; Malissa M Reyes; Ann M Gregus; Matthew W Buczynski Journal: J Neurosci Methods Date: 2019-10-12 Impact factor: 2.390
Authors: Alexsandra Ratajczak; Wojciech Feleszko; Danielle M Smith; Maciej Goniewicz Journal: Expert Rev Respir Med Date: 2018-06-08 Impact factor: 3.772
Authors: Jessica L King; Beth A Reboussin; Julie W Merten; Kimberly D Wiseman; Kimberly G Wagoner; Erin L Sutfin Journal: Addict Behav Date: 2020-01-13 Impact factor: 3.913
Authors: Gideon St Helen; Evangelia Liakoni; Natalie Nardone; Newton Addo; Peyton Jacob; Neal L Benowitz Journal: Cancer Prev Res (Phila) Date: 2019-09-25
Authors: Joesph R Wiencek; Eric A Gehrie; Amaris M Keiser; Penny C Szklarski; Kamisha L Johnson-Davis; Garrett S Booth Journal: Am J Clin Pathol Date: 2019-04-02 Impact factor: 2.493
Authors: Erin A Vogel; Judith J Prochaska; Danielle E Ramo; Jerome Andres; Mark L Rubinstein Journal: J Adolesc Health Date: 2019-06 Impact factor: 5.012